There were increased levels of ET-1 (1.58 ± 0.65 pg/mL vs. 1.09 ± 0.38 pg/mL; p < 0.001) in OSA patients as compared with healthy controls (Figure 2). This evidence concerns the gene EDN1 and obstructive sleep apnea syndrome.